Skip to contentN
NEUROONE MEDICAL TECHNOLOGIES Corp
N
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp Q3 2026 · 10-Q
Revenue$1.97M$1.97M+16.3% vs Q3 2025 Net Income-$2.01M-$2.01MN/M vs Q3 2025 EPS Diluted-$0.28-$0.28N/M vs Q3 2025 Gross Profit$1,182,609+29.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NEUROONE MEDICAL TECHNOLOGIES Corp · CIK 1500198 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,081,789N/M Free Cash Flowderived-$1,101,448N/M Margins · derivedGross margin59.9%+6.0 pt vs Q3 2025
Operating margin-122.9%−11.6 pt vs Q3 2025
Net margin-101.7%−13.2 pt vs Q3 2025
ended Jun 30, 2026 · filed Aug 13, 2026 · 44 d after period end